That's a company that seems similar to Springtree in function.
Here is the company's website they refer to, and it shows that PRR is not the only company working on dendritic cell based immunotherapy:
http://www.quantumimmunologics.com/
You can rest assured that there is an explosion of research in this area of cancer immunotherapy now that the FDA has given the first approval for such therapy (DNDN).
Prima is well down the research pathway, but remember that such research takes a long time and any problems along the way can stall progress significantly.
Here's hoping though..............
- Forums
- ASX - By Stock
- IMM
- mentor listing
mentor listing, page-2
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 388130 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 39940 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 270952 | 0.295 |
4 | 46150 | 0.290 |
5 | 90665 | 0.285 |
10 | 129639 | 0.280 |
6 | 212272 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 36348 | 1 |
0.305 | 57701 | 5 |
0.310 | 236689 | 5 |
0.315 | 110917 | 5 |
0.320 | 130000 | 3 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |